ORYZON to present at upcoming international conferences
MADRID, SPAIN and CAMBRIDGE MA.
- 25th Annual International Partnering Conference BIO-Europe-2019, Hamburg, Germany
- Jefferies London Healthcare Conference, London, UK
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical needs, announced today that Executive Directors of the company will present at several reputed international conferences in November.